Regulatory News
Wednesday, February 1, 2017
BRIEF-Tetra Bio-Pharma receives notice of authorization from Health Canada
* Tetra Bio-Pharma Inc receives notice of authorization from
Health Canada for the conduct of its clinical trial with its
PPTGR topical product
Source text for Eikon:
Further company coverage:
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment